Results 101 to 110 of about 14,542 (144)

Brute force: the effects of ibrutinib on brexu-cel. [PDF]

Blood Adv
Peterson CE, Betts BC.
europepmc   +1 more source

Resilience of human tolerogenic dendritic cells to physiological oxygen supports clinical application: functional stability amidst glycolytic and differentiation shifts. [PDF]

Exp Hematol Oncol
Peter A, Traitteur T, Calitz S, Vermeulen M, Van Delen M, Dams A, Peeters S, Faghel C, De Reu H, Marei WFA, Berneman ZN, Cools N.   +11 more
europepmc   +1 more source

Tailoring monocyte-derived tolerogenic cell therapies to the needs; what's in a name? [PDF]

Mol Ther Methods Clin Dev
Nikolic T, Roep BO.
europepmc   +1 more source

Decoding PFAS immunotoxicity: a NAMs-based comparison of short vs. long chains. [PDF]

Front Toxicol
Iulini M, Galbiati V, Marinovich M, Corsini E.   +3 more
europepmc   +1 more source

Genomic innovation in precision oncology: integrated CRISPR-TTP bioengineering architecture for Ewing Sarcoma (version 4.0 - complete architectural specification). [PDF]

Front Genet
Burlai AM.
europepmc   +1 more source

A Xeno-Free Protocol for Rapid Differentiation of Human iPSC-Derived Microglia from the KOLF2.1J Reference Line. [PDF]

Bioengineering (Basel)
Oliveira NAJ, Lewkowicz KR, Clow PA, Ward ME, Cookson MR, Skarnes WC, McDonough JA.   +6 more
europepmc   +1 more source

Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis. [PDF]

Front Immunol
Chyb M, Bekier A, Kawka M, Ferra B, Dziadek B, Michlewska S, Dzitko K, Trotsko N, Gatkowska J.   +8 more
europepmc   +1 more source

Molecular cloning and characterization of duck CD83 and its effect on H9N2 avian influenza virus replication. [PDF]

Poult Sci
Li H, Xin X, Yin Z, Dong C, Li F, Liu Y, Kong X, Wang L, Wang J, Yu F, Huo S.   +10 more
europepmc   +1 more source

Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. [PDF]

Clin Transl Med
Zhang S, Fu Q, Xu Z, Wang S, You G, Su X, Yuan X, Liu C, Liu C, Zhang C, Liu B, Gong Y.   +11 more
europepmc   +1 more source

CD83 suppresses endogenous March-I-dependent MHC class II ubiquitination, endocytosis, and degradation. [PDF]

Proc Natl Acad Sci U S A
Kaul S, Cole NB, Bandola-Simon J, Lu Y, Tondini E, Walseng E, Roche PA.   +6 more
europepmc   +1 more source